Clinical Trial Update: A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion). [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation trial of SPYK04 in locally advanced or metastatic solid tumors is ongoing with expansion cohorts; the study is currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Metastatic Solid Tumors

Drugs mentioned

• SPYK04 (SPYK04)

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Locally Advanced or Metastatic Solid Tumors | Phase 1 | Status: ACTIVE_NOT_RECRUITING